|
|
 |
|
 |
|
| 1 |
Utsumi T, Suzuki H, Ishikawa H, Hiroshima Y, Wakatsuki M, Harada M, Ichikawa T, Akakura K, Tsuji H. External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort study. Jpn J Clin Oncol 2022 Aug 5;52(8):942-945 doi:10.1093/jjco/hyac066. PMID: 35462397
|
| 2 |
Shiota M, Takamatsu D, Kimura T, Tashiro K, Matsui Y, Tomida R, Saito R, Tsutsumi M, Yokomizo A, Yamamoto Y, Edamura K, Miyake M, Morizane S, Yoshino T, Matsukawa A, Narita S, Matsumoto R, Kasahara T, Hashimoto K, Matsumoto H, Kato M, Akamatsu S, Joraku A, Kato M, Yamaguchi T, Saito T, Kaneko T, Takahashi A, Kato T, Sakamoto S, Enokida H, Kanno H, Terada N, Suekane S, Nishiyama N, Eto M, Kitamura H; Japanese Urological Oncology Group. Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancerc.
Cancer Sci 2022 Jul;113(7):2386-2396. doi: 10.1111/cas.15383. Epub 2022 May 17PMID: 3548563
5 |
| 3 |
Wakai K, Azuma K, Iwamura C, Maimaiti M, Mikami K, Yoneda K, Sakamoto S, Ikehara S, Yamaguchi T, Hirahara K, Ichikawa T, Nakayama T, Ikehara Y.
The new preparation method for paraffin-embedded samples applying scanning electron microscopy revealed characteristic features in asthma-induced mice. Sci Rep. 2022 May 31;12(1):9046. doi: 10.1038/s41598-022-12666-8. PMID: 3564158
5 |
| 4 |
Ishikawa H, Hiroshima Y, Kanematsu N, Inaniwa T, Shirai T, Imai R, Suzuki H, Akakura K, Wakatsuki M, Ichikawa T, Tsuji H. Carbon-ion radiotherapy for urological cancers.
Int J Urol 2022 Oct;29(10):1109-1119. doi: 10.1111/iju.14950. Epub 2022 Jun 12. PMID: 3569212
4 |
| 5 |
Arai T, Sazuka T, Sato H, Imamura Y, Sakamoto S, Ichikawa T. Efficacy of photodynamic diagnosis-assisted transurethral resection of bladder tumor for T1 bladder cancer: Novel second transurethral resection initiatives utilizing photodynamic diagnosis.
Int J Urol 2022 Oct;29(10):1238-1240. doi: 10.1111/iju.14962. Epub 2022 Jun 20. PMID: 35726052
|
| 6 |
Arai T, Sazuka T, Sato H, Kato M, Kamada S, Katsura S, Seito A, Miyamoto S, Wakai K, Takeuchi N, Imamura Y, Sakamoto S, Komiya A, Ichikawa T. A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study. Int J Clin Oncol 2022 Sep;27(9):1467-1476. doi: 10.1007/s10147-022-02204-x. Epub 2022 Jun 29. . PMID: 35767079
|
| 7 |
Takuma Kato, Akira Yokomizo, Ryuji Matsumoto, Yoichiro Tohi, Jimpei Miyakawa, Koji Mitsuzuka, Hiroshi Sasaki, Junichi Inokuchi, Masafumi Matsumura, Shinichi Sakamoto, Hidefumi Kinoshita, Hiroshi Fukuhara, Naoto Kamiya, Ryu Kimura, Masahiro Nitta, Hiroshi Okuno, Koichiro Akakura, Yoshiyuki Kakehi, Mikio Sugimoto Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study Int J Urol 2022 Nov;29(11):1271-1278 doi: 10.1111/iju.14977 Epub 2022 Jul 19 PMID: 35855586
|
| 8 |
Minemura C, Asai S, Koma A, Kikkawa N, Kato M, Kasamatsu A, Uzawa K, Hanazawa T, Seki N. Identification of Antitumor miR-30e-5p Controlled Genes; Diagnostic and Prognostic Biomarkers for Head and Neck Squamous Cell Carcinoma. Genes (Basel). 2022 Jul 9;13(7):1225. doi: 10.3390/genes13071225. PMID: 35886008
|
| 9 |
Tamura T, Yoshioka Y, Sakamoto S, Ichikawa T, Ochiya T. Extracellular vesicles in bone homeostasis: key roles of physiological and pathological conditions. J Bone Miner Metab. 2023 May;41(3):345-357. doi: 10.1007/s00774-022-01362-2. Epub 2022 Aug 9. PMID: 35943593
|
| 10 |
Hiroshima Y, Ishikawa H, Iwai Y, Wakatsuki M, Utsumi T, Suzuki H, Akakura K, Harada M, Sakurai H, Ichikawa T, Tsuji H. Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer. Cancers (Basel). 2022 Aug 19;14(16):4015. doi: 10.3390/cancers14164015. PMID: 36011007
|
| 11 |
Kaga K, Yamanishi T, Shibata C, Kamasako T, Kaga M, Fuse M. The Efficacy of Compression Stockings on Patients With Nocturia: A Single-Arm Pilot Study. Cureus. 2022 Aug 30;14(8):e28603. doi: 10.7759/cureus.28603. eCollection 2022 Aug. PMID: 36185903
|
| 12 |
Yasudome R, Seki N, Asai S, Goto Y, Kita Y, Hozaka Y, Wada M, Tanabe K, Idichi T, Mori S, Ohtsuka T. Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive miR-139-3p. Int J Mol Sci. 2022 Oct 1;23(19):11616. doi: 10.3390/ijms231911616. PMID: 36232922
|
| 13 |
Pae S, Sakamoto S, Zhao X, Saito S, Tamura T, Imamura Y, Sazuka T, Reien Y, Hirayama Y, Hashimoto H, Kanai Y, Ichikawa T, Anzai N. Targeting L-type amino acid transporter 1 in urological malignancy: Current status and future perspective. J Pharmacol Sci. 2022 Dec;150(4):251-258. doi: 10.1016/j.jphs.2022.10.002. Epub 2022 Oct 7. PMID: 36344047
|
| 14 |
Nishikawa R, Miyake M, Morizane S, Shimizu R, Teraoka S, Honda M, Iida K, Nishimura N, Sazuka T, Kimura T, Ito A, Shiga K, Taoka R, Kojima T, Kobayashi T, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K, Takenaka A. C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guerin therapy: A Japan Urological Oncology Group study analysis. Int J Urol. 2023 Mar;30(3):299-307. doi: 10.1111/iju.15106. Epub 2022 Nov 30. PMID: 36448522
|
| 15 |
Goto Y Editorial comment to real-world outcomes of pembrolizumab for platinum refractory advanced urothelial carcinoma: Efficacy, safety, and evidence for trial-unfit patients. Int J Urol. 2023 Sep;30(9):704. doi: 10.1111/iju.15113. Epub 2022 Dec 9. PMID: 36482811
|
| 16 |
Baba H, Sakamoto S, Zhao X, Yamada Y, Rii J, Fujimoto A, Kanesaka M, Takeuchi N, Sazuka T, Imamura Y, Akakura K, Ichikawa T.
Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer. Cancers (Basel). 2022 Nov 25;14(23):5823. doi: 10.3390/cancers14235823. PMID: 36497304
|
| 17 |
Takeshita N, Sakamoto S, Kitaguchi D, Takeshita N, Yajima S, Koike T, Ishikawa Y, Matsuzaki H, Mori K, Masuda H, Ichikawa T, Ito M. Deep Learning-Based Seminal Vesicle and Vas Deferens Recognition in the Posterior Approach of Robot-Assisted Radical Prostatectomy. Urology. 2023 Mar;173:98-103.doi: 10.1016/j.urology.2022.12.006. Epub 2022 Dec 23. PMID: 36572225
|
| 18 |
Chen X, Higo T, Tanaka K, Nomoto T, Tsai H, Idzuchi H, Shiga M, Sakamoto S, Ando R, Kosaki H, Matsuo T, Nishio-Hamane D, Arita R, Miwa S, Nakatsuji S. Octupole-driven magnetoresistance in an antiferromagnetic tunnel junction. Nature. 2023 Jan;613(7944):490-495. doi: 10.1038/s41586-022-05463-w. Epub 2023 Jan 18. PMID: 36653566
|
| 19 |
Asai S, Goto Y, Tanigawa K, Tomioka Y, Kato M, Mizuno K, Sakamoto S, Seki N. MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3 FEBS Lett. 2023 Apr;597(8):1164-1175. doi: 10.1002/1873-3468.14598. Epub 2023 Feb 20. PMID: 36754848
|
| 20 |
Takeshita N, Sakamoto S, Yamada Y, Sazuka T, Imamura Y, Komiya A, Akakura K, Sato N, Nakatsu H, Kato T, Sugimoto M, Tsuzuki T, Ichikawa T.
Detection of intraductal carcinoma in prostate cancer patients with small tumor volume. Prostate. 2023 May;83(6):580-589. doi: 10.1002/pros.24492. Epub 2023 Feb 10. PMID: 3676241
9 |
| 21 |
Kanya Kaga, Tomonori Yamanishi, Tomohiko Kamasako, Mayuko Kaga, Miki Fuse, Mitsuru Ishizuka, Efficacy of Transcutaneous Tibial Nerve Stimulation With Silver Spike PointR Electrodes for Refractory Overactive Bladder: A Single-Arm Study. Cureus. 2023 Jan 24;15(1):e34166. doi: 10.7759/cureus.34166. eCollection 2023 Jan. PMID: 36843763
|
| 22 |
Goto Y Editorial Comment to Stereotactic body radiation therapy for kidney cancer. Where do we stand? Int J Urol. 2023 May;30(5):445-446. doi: 10.1111/iju.15167. Epub 2023 Feb 28. PMID: 36852924
|
| 23 |
Ryo Tsukamoto, Tomokazu Sazuka, Yoshinori Hattori, Hiroaki Sato, Takayuki Ara, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Tomohiko Ichikawa Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data Cancers (Basel) 2023Mar7;15(6):1638. doi: 10.3390/cancers15061638. PMID: 36980524 PMCID: PMC10046501 DOI: 10.3390/cancers15061638
|
|
 |
|
| 1 |
Goto Y, Tanaka S, Maruo M, Sugawara S, Chiba K, Miyazaki K, Inoue A, Ichikawa T, Nagata M. Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis. IJU Case Rep. 2022 May 9;5(4):304-307. doi: 10.1002/iju5.12463. eCollection 2022 Jul. PMID: 35795120
|
| 2 |
Hiroaki Sato, Tomokazu Sazuka, Ayumi Fujimoto, Sakurako Kagitani, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Jun-Ichiro Ikeda, Tomohiko Ichikawa A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy
IJU Case Rep 2023 Mar 19;6(3):185-189.doi: 10.1002/iju5.12584. eCollection 2023 May. PMID: 37144081 PMCID: PMC10151202 DOI: 10.1002/iju5.12584
|
|
 |
|
| 1 |
Tamura T, Yoshioka Y, Sakamoto S, Ichikawa T, Ochiya T. Extracellular vesicles in bone homeostasis: key roles of physiological and pathological conditions. J Bone Miner Metab. 2022 Aug 9. doi: 10.1007/s00774-022-01362-2. Online ahead of print. PMID: 35943593
|
| 2 |
Xue Zhao , Shinichi Sakamoto, Jiaxing Wei, Sangjon Pae, Shinpei Saito, Tomokazu Sazuka, Yusuke Imamura, Naohiko Anzai.Tomohiko Ichikawa Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer Int J Mol Sci. 2023 Mar 24;24(7):6178. doi: 10.3390/ijms24076178. PMID: 37047148 PMCID: PMC10094571 DOI: 10.3390/ijms24076178
|
|
|
|
|
|
|
|
|
|
|
|
|
